Ion channel drug discovery expands into new disease areas

Current Drug Discovery

Volumn , Issue APR., 2004, Pages 31-33

  Xie, Michael ^a   Holmqvist, Mats H ^a   Hsia, Albert Y ^a  

^a Synta Pharmaceuticals Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMLODIPINE BESYLATE; ION CHANNEL; NATEGLINIDE; REPAGLINIDE; SULFONYLUREA; ZOLPIDEM TARTRATE;

ANXIETY DISORDER; ARTICLE; CANCER; DIABETES MELLITUS; DRUG TARGETING; IMMUNOPATHOLOGY; INSOMNIA; RECEPTOR POTENTIAL;

EID: 2442573935     PISSN: 14727463     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)